These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24132302)

  • 21. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C; Abraham JL
    J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D; Johnsen H; Juelsrud A; Løvhaug D
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis.
    Kaewlai R; Abujudeh H
    AJR Am J Roentgenol; 2012 Jul; 199(1):W17-23. PubMed ID: 22733927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital.
    Zou Z; Ma L; Li H
    J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique dinuclear mixed V(V) oxo-peroxo complex in the structural speciation of the ternary V(V)-peroxo-citrate system. potential mechanistic and structural insight into the aqueous synthetic chemistry of dinuclear V(V)-citrate species with H2O2.
    Kaliva M; Gabriel C; Raptopoulou CP; Terzis A; Voyiatzis G; Zervou M; Mateescu C; Salifoglou A
    Inorg Chem; 2011 Nov; 50(22):11423-36. PubMed ID: 22029259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
    Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.
    Pietsch H; Raschke M; Ellinger-Ziegelbauer H; Jost G; Walter J; Frenzel T; Lenhard D; Hütter J; Sieber MA
    Invest Radiol; 2011 Jan; 46(1):48-56. PubMed ID: 20938346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metal complexation and biodegradation of EDTA and S,S-EDDS: a density functional theory study.
    Chen L; Liu T; Ma C
    J Phys Chem A; 2010 Jan; 114(1):443-54. PubMed ID: 20017479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI.
    Accardo A; Tesauro D; Roscigno P; Gianolio E; Paduano L; D'Errico G; Pedone C; Morelli G
    J Am Chem Soc; 2004 Mar; 126(10):3097-107. PubMed ID: 15012139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic systemic fibrosis: the need for accurate case reporting.
    Spinazzi A; Kirchin MA; Pirovano G
    J Magn Reson Imaging; 2009 May; 29(5):1240; author reply 1241. PubMed ID: 19388104
    [No Abstract]   [Full Text] [Related]  

  • 32. A highly stable gadolinium complex with a fast, associative mechanism of water exchange.
    Thompson MK; Botta M; Nicolle G; Helm L; Aime S; Merbach AE; Raymond KN
    J Am Chem Soc; 2003 Nov; 125(47):14274-5. PubMed ID: 14624565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From structural properties of the EuIII complex with ethylenediaminetetra(methylenephosphonic acid) (H8EDTMP) towards biomedical applications.
    Mondry A; Janicki R
    Dalton Trans; 2006 Oct; (39):4702-10. PubMed ID: 17028679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
    Steger-Hartmann T; Raschke M; Riefke B; Pietsch H; Sieber MA; Walter J
    Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.
    Dawson P
    J Magn Reson Imaging; 2008 Oct; 28(4):797-804. PubMed ID: 18821621
    [No Abstract]   [Full Text] [Related]  

  • 36. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability constants and 1H relaxation effects of ternary complexes formed between Gd-DTPA, Gd-DTPA-BMA, Gd-DOTA, and Gd-EDTA and citrate, phosphate, and carbonate ions.
    Burai L; Hietapelto V; Király R; Tóth E; Brücher E
    Magn Reson Med; 1997 Jul; 38(1):146-50. PubMed ID: 9211390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordination chemistry of the solvated AgI and AuI ions in liquid and aqueous ammonia, trialkyl and triphenyl phosphite, and tri-n-butylphosphine solutions.
    Nilsson KB; Persson I; Kessler VG
    Inorg Chem; 2006 Aug; 45(17):6912-21. PubMed ID: 16903749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.
    Pietsch H; Pering C; Lengsfeld P; Walter J; Steger-Hartmann T; Golfier S; Frenzel T; Hütter J; Weinmann HJ; Sieber MA
    J Magn Reson Imaging; 2009 Aug; 30(2):374-83. PubMed ID: 19629978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimeric dioxomolybdenum(VI) and oxomolybdenum(V) complexes with citrate at very low pH and neutral conditions.
    Zhou ZH; Deng YF; Cao ZX; Zhang RH; Chow YL
    Inorg Chem; 2005 Oct; 44(20):6912-4. PubMed ID: 16180846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.